Cetilistat
Cetilistat (ATL-962) is a pancreatic lipase inhibitor developed for obesity and type 2 diabetes management. It functions by reducing dietary fat absorption and has been investigated in both in vitro enzymatic assays and in vivo preclinical models of metabolic disease.
Product Specifications
CAS Number
282526-98-1
Product Name Alternative
Inhibit, Lipase, lipase, pancreatic, Inhibitor, high-fat diet, anti-obesity, ATL 962, ATL962, ATL-962, cholesterol, Cetilistat
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
97.12% (May vary between batches)
Solubility
DMSO:Insoluble; H2O:Insoluble
Smiles
O=C1C=2C (N=C (OCCCCCCCCCCCCCCCC) O1) =CC=C (C) C2
Molecular Formula
C25H39NO3
Molecular Weight
401.58
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ABC-X2754 1 Vial
Xpress™ Human SDAD1 Over-expressing Stable Cell Line
Sign In for Pricing
View Details MBS6312138-02 5x 0.2 mL
KAZ, CT (KAZN, KAZ, KIAA1026, Kazrin) (APC)
Sign In for Pricing
View Details 